Edward Shanbrom

Q: What Schools Are Affiliated With Edward Shanbrom

Edward Shanbrom is affiliated with the following schools: University of Arkansas for Medical Sciences, University at Buffalo, University of California, Irvine, University of California, Los Angeles, Allegheny College

Edward Shanbrom's AcademicInfluence.com Rankings

Edward Shanbrom

Medical

#1214

World Rank

#1533

Historical Rank

#357

USA Rank

Hematology

#24

World Rank

#27

Historical Rank

#10

USA Rank

medical Degrees

Edward Shanbrom

Philosophy

#11791

World Rank

#16292

Historical Rank

#2267

USA Rank

Logic

#8596

World Rank

#10777

Historical Rank

#1432

USA Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Edward Shanbrom Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Edward Shanbrom was an American medical researcher and hematologist, best known for the development of the process allowing the clotting protein Factor VIII to be made to treat hemophilia. Early life and education Edward Shanbrom was born in West Haven, Connecticut, United States, and served in the United States Navy from 1943 to 1946. He then received a Bachelor of Science from Allegheny College, and a medical degree from the University of Buffalo School of Medicine. Following an internship for the Buffalo University Hospital, Shanbrom received a fellowship to Yale University, where he studied hematology. After the fellowship, he served Orange County General Hospital, St. Joseph Hospital, and City of Hope Medical Center. During that time he was a clinical instructor at UCLA and UC Irvine.

(See a Problem?)

Edward Shanbrom's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Antioxidant capacity and other bioactivities of the freeze-dried Amazonian palm berry, Euterpe oleraceae mart. (acai). (2006) (325)
Acute Childhood Leukaemia in Relation to the HL–A Human Transplantation Genes (1970) (108)
Antibacterial activity of vegetables and juices. (2003) (108)
A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors. (1968) (96)
The role of systemic blood pressure in cerebral circulation in carotid and basilar artery thromboses; clinical observations and therapeutic implications of vasopressor agents. (1957) (64)
Herpes zoster in hematologic neoplasias: some unusual manifestations. (1960) (58)
Antibacterial activity of citrate and acetate. (2002) (54)
Critical evaluation of massive steroid therapy of acute leukemia. (1962) (47)
Liver damage after chemotherapy for leukemia and lymphoma. (1962) (42)
The Preparation and Evaluation of a Standardized Fibrin Plate for the Assessment of Fibrinolytic Activity (1970) (37)
Radiographic studies of the lymphatic system. (1959) (35)
Contrast visualization of lymph nodes. (1958) (31)
Fibrinolytic activity in acute myocardial infarction. (1972) (29)
INFECTIOUS SYNDROMES OF LEUKEMIAS AND LYMPHOMAS (1963) (29)
The Auditory Manifestations of Leukemia (1958) (26)
Long‐term Plasmapheresis: Effects on Specific Plasma Proteins (1972) (26)
Rapid detection of Gram-negative bacteriuria by Limulus amoebocyte lysate assay (1981) (26)
Evaluation of a new concentrate for the treatment of factor IX deficiency. (1969) (25)
Experimental prophylaxis of severe hemophilia with a factor VIII concentrate. (1969) (24)
Bactericidal activity of citrate against Gram‐positive cocci (2001) (23)
The systemic manifestations of Sjögren's syndrome: report of glandular function with histologic, bacterial and viral studies. (1958) (22)
Treatment of herpetic pain and postherpetic neuralgia with intravenous procaine. (1961) (21)
Anti-microbial Activity of Urine after Ingestion of Cranberry: A Pilot Study (2008) (19)
Inactivation of lipid‐enveloped and non‐lipid‐enveloped model viruses in normal human plasma by crosslinked starch‐iodine (1994) (16)
Immunodiffusion techniques in clinical medicine. II. Radial immunodiffusion. (1967) (16)
Iodine-mediated inactivation of lipid- and nonlipid-enveloped viruses in human antithrombin III concentrate. (1995) (15)
Immunodiffusion techniques in clinical medicine. I. Immunoelectrophoresis. (1967) (15)
“ACQUIRED” PELGER‐HUËT CELLS IN BLOOD DYSCRASIAS (1960) (14)
Antisera for tissue-typing: the production of cytotoxic and agglutinating antibodies following intradermal leukocyte injections in man. (1968) (14)
Therapeutic spectrum of uracil-mustard, a new oral antitumor drug. With special reference to the effects of small dosage in lymphomas, chronic leukemias, and ovarian carcinoma. (1960) (14)
Viral inactivation of vesicular stomatitis virus in normal human serum by cross-linked polyvinylpyrrolidone. (1993) (13)
Undegraded γ‐Globulin for Intravenous Therapy (1971) (12)
Acquired Pelger-Huet granulocytes in severe myxedema. (1962) (12)
The treatment of leukemic priapism with A-139. (1960) (11)
Intrathecal administration of amethopterin in leukemic encephalopathy of young adults. (1961) (10)
Gastrointestinal complications of colchicine therapy in gout. (1958) (9)
Prothrombin complex concentrate: Use in controlling the hemorrhagic diathesis of chronic liver disease (1975) (9)
A Simple Procedure for Accurate Quantitation of Factor VIII Inhibitors (1970) (9)
Glycine-precipitated antihemophilic factor concentrates and their clinical use. (1968) (9)
Lc‐11 (Hunt B, Jones) as a Mutually Exclusive Specificity to Lc‐1, 2, and 3 in the Main Human Leukocyte Group 1 (1968) (8)
Multiple Myeloma and Coexistent Carcinoma of the Sigmoid Colon: A Review of the Literature and Report of Four Cases (1963) (8)
OBSERVATIONS ON THE INHIBITION OF ERYTHROCYTE SEDIMENTATION BY LOW MOLECULAR WEIGHT DEXTRAN (1963) (8)
Lactic dehydrogenase isoenzyme electrophoresis. (1968) (6)
Radiologic sign in hemosiderosis. (1958) (5)
Undegraded -globulin for intravenous therapy. A new preparation of immune serum globulin for intravenous administration. (1971) (4)
Can Hemophilic Patients Be Adequately Maintained with Cryoprecipitates? Or Is it Desirable or Even Necessary to Manufacture and Administer Highly Concentrated AHF Products? (1972) (4)
Prolonged remissions in acute myelocytic leukemia in adults. (1968) (4)
Multiple myeloma and coexistent carcinoma of the sigmoid colon. (1963) (3)
Factor V: a Simplified One-Stage Assay using a Stabilized Artificial Substrate (1973) (3)
The antifungal activity of urine after ingestion of cranberry products. (2009) (3)
Latex reagent for determining IgM levels in cord and newborn sera. (1969) (3)
Cascade iodination: a novel method to enhance the safety and efficacy of therapeutic proteins (2004) (2)
Novel cryoprecipitate for wound healing and skin grafts in rats (2008) (2)
Treatment of leukemia cutis with demecolcin. (1957) (2)
Studies toward the definition of human lymphocyte isoantigens. (1968) (2)
Hemoglobin electrophoresis. (1967) (2)
Multiple hematologic abnormalities in a case of postnecrotic cirrhosis. (1961) (2)
Modern Treatment of Hemophilia with a Potent, New AHF Concentrate (1972) (2)
Endobronchial geotrichosis. (1954) (2)
Rapid correction of AHF deficiency by antihemophilic factor-method four, with special reference to inhibitors. (1970) (2)
Clinical Evaluation of a New Intravenous Gamma Globulin. (1970) (2)
Hemophilia, rodentophilia and humanity (2003) (2)
Pyrogenicity versus endotoxicity: which is more significant? (1982) (1)
Malthus, morality, and "miracle" drugs. (1962) (1)
Is the Poor Recovery of Commercial Recombinant Factors VIII and IX caused by Damage from Monoclonal Antibody Purification? (2002) (1)
PROGNOSTIC VALUE OF URIC ACID EXCRETION IN STEROID THERAPY OF ACUTE LEUKEMIA (1962) (1)
A polyvalent latex slide test for rapid screening of syphilis in blood donors. (1968) (1)
Visceral manifestations of American mucocutaneous leishmaniasis. (1956) (1)
An Unusual Occurrence of Anti‐Xga (1969) (1)
Production of Defined Human Leukocyte Typing Sera (1972) (1)
Choice of replacement therapy for hemophilia—reply to a rebuttal (2003) (1)
Is citrate deficiency universal? (2005) (0)
A process for preparing a concentrate of the prothrombin complex (1981) (0)
Newer aspects in the diagnosis and treatment of lymphomas and leukemias. (1959) (0)
Haptoglobin electrophoresis. (1968) (0)
Preparing a bone for transplantation. (1992) (0)
A process for preparing kondentrater of the prothrombin complex which is purified to high purity thus obtained concentrates and their use (1981) (0)
Selective Lympholysis: A Unique Method Using the Double-Dye Technique. (2006) (0)
Preparation and Use of a Potent, New Antihemophilic Concentrate. (1969) (0)
Diagnostic application of immunoglobulin determinations. (1970) (0)
Preparing Citrated Non-Activated Gamma Globulin for Rapid Infusion. (2004) (0)
Process for the preparation of highly purified concentrate of prothrombin complex, and concentrates obtained (1979) (0)
Antimicrobial activity of urine after ingestion of cranberry (2005) (0)
Procede de preparation d'un concentre de facteur viii (1980) (0)
Recognition and treatment of the various seizure disorders in medical practice. (1956) (0)
Method dye mixture to inactivate pathogens circulating blood. (2004) (0)
United States Patent 19 Shanbrom (2017) (0)
PROGRAM OF THE CONFERENCE ON CONTINUING MEDICAL EDUCATION. ACTIVITIES AND ATTITUDES OF COUNTY MEDICAL SOCIETIES. (1965) (0)
Pepto-bismol and salicylate levels. (1989) (0)
Factor V: a simplified one-stage using a stabilized artificial substrate. (1973) (0)
FRACTIONATION OF PLASMA USING GLYCINE AND POLYETHYLENE GLYCOL (2017) (0)
Congenital hypersplenism with pancytopenia and basophilic stippling: therapeutic failure of ACTH and splenectomy. (1954) (0)
A process for preparing a concentrate of the stable antihamophilen factor with high efficiency (1968) (0)
A process for the preparation of a concentrate of the prothrombin complex (1980) (0)
5128149 Enhanced blood product antiviral process and product produced (1993) (0)
Antiviral blood sampling process and apparatus (1993) (0)
ADDENDUM (1958) (0)
Advances in cancer chemotherapy. (1961) (0)
CRYOPRECIPITATE EXTRACTION OF CLOTTING FACTORS (2017) (0)
Preparation of a bone, for a transplant (1992) (0)

This paper list is powered by the following services:

Other Resources About Edward Shanbrom

en.wikipedia.org

What Schools Are Affiliated With Edward Shanbrom?

Edward Shanbrom is affiliated with the following schools:

Edward Shanbrom's Academic­Influence.com Rankings

Why Is Edward Shanbrom Influential?

Edward Shanbrom's Published Works

Published Works

Other Resources About Edward Shanbrom

What Schools Are Affiliated With Edward Shanbrom?

Edward Shanbrom's AcademicInfluence.com Rankings